Publications by authors named "Norma Deri"

Claim this Profile
D
Determination of disability progression in moderately and highly disabled ambulatory patients with relapsing-remitting multiple sclerosis using the EDSS-Plus: A prospective study in Argentina.
Ricardo Alonso, Maria Barbara Eizaguirre, Magdalena Casas, Luciana Lazaro, Alfredo Laffue, Norma Deri

Mult Scler Relat Disord· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Standardized Definition of Progression Independent of Relapse Activity (PIRA) in Relapsing-Remitting Multiple Sclerosis.
Jannis Müller, Sifat Sharmin, Johannes Lorscheider, Serkan Ozakbas, Rana Karabudak, Norma Deri

JAMA Neurol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Explainable time-to-progression predictions in multiple sclerosis.
Robbe D'hondt, Klest Dedja, Sofie Aerts, Bart Van Wijmeersch, Tomas Kalincik, Norma Deri

Comput Methods Programs Biomed· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Routine CSF parameters as predictors of disease course in multiple sclerosis: an MSBase cohort study.
Cathérine Dekeyser, Matthias Hautekeete, Melissa Cambron, Vincent Van Pesch, Francesco Patti, Norma Deri

J Neurol Neurosurg Psychiatry· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Traditional first-line treatment failure rates in neuromyelitis optica spectrum disorder patients included in the Argentinean registry (RelevarEM).
Edgar Carnero Contentti, Pablo A Lopez, Liliana Patrucco, Edgardo Cristiano, Jimena Miguez, Norma Deri

Mult Scler Relat Disord· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Do immunosuppressive treatments influence immune responses against adenovirus-based COVID-19 vaccines in patients with multiple sclerosis? An Argentine multicenter study.
Berenice Anabel Silva, Esteban Miglietta, Juan Cruz Casabona, Shirley Wenker, María Bárbara Eizaguirre, Federico Man, Federico Casales, Norma Deri

Front Immunol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Occurrence of area postrema syndrome during follow-up: phenotype and influence over NMOSD activity in LATAM in real-world settings.
Claudia Pestchanker, Brenda Bertado Cortez, Marco A Lana Peixoto, José Ignacio Gortari, Sheila Castro Suarez, Norma Deri

J Neurol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment strategies and responses for attacks of neuromyelitis optica spectrum disorder: A real-world retrospective cohort study.
Edgar Carnero Contentti, Pablo A Lopez, Juan Pablo Pettinicchi, Jimena Miguez, Liliana Patrucco, Norma Deri

J Neurol Sci· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Effectiveness and Safety of Cladribine in Multiple Sclerosis: Longitudinal Data From the Nationwide Registry in Argentina.
Juan Ignacio Rojas, Ricardo Alonso, Geraldine Luetic, Liliana Patrucco, Magdalena Casas, Norma Deri

Clin Neuropharmacol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Machine-learning-based prediction of disability progression in multiple sclerosis: An observational, international, multi-center study.
Edward De Brouwer, Thijs Becker, Lorin Werthen-Brabants, Pieter Dewulf, Dimitrios Iliadis, Norma Deri

PLOS Digit Health· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selection of disease modifying therapies in multiple sclerosis based on patient's age and disease activity: Data from a nationwide registry.
Maria A Piedrabuena, Jorge Correale, Marcela Fiol, Mariano Marrodan, Juan I Rojas, Norma Deri

J Neurol Sci· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical characterization of long-term multiple sclerosis (COLuMbus) patients in Argentina: A cross-sectional non-interventional study.
Norma Deri, Andres Barboza, Carlos Vrech, Roberto Rey, Marcos Burgos, Maria B Federico

Mult Scler Relat Disord· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of SARS-CoV-2 infection in patients with multiple sclerosis who received SARS-CoV-2 vaccines and are under treatment with high-efficacy therapies in Argentina.
Edgar Carnero Contentti, Pablo A López, Agustín Pappolla, Ricardo Alonso, Berenice Silva, Norma Deri, Belén Federico

Neurol Sci· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The risk of secondary progressive multiple sclerosis is geographically determined but modifiable.
Sifat Sharmin, Izanne Roos, Steve Simpson-Yap, Charles Malpas, Marina M Sánchez, Norma Deri

Brain· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the use of high-efficacy treatments (HETs) in patients with relapsing-remitting multiple sclerosis in Argentina.
Ricardo Alonso, Magdalena Casas, Luciana Lazaro, Nora Fernandez Liguori, Cecilia Pita, Norma Deri

Mult Scler Relat Disord· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mortality of neuromyelitis optica spectrum disorder patients in an Argentinean population: A study from the RelevarEM registry.
Edgar Carnero Contentti, Pablo A Lopez, Juan Pablo Pettinicchi, Juan Criniti, Agustín Pappolla, Norma Deri

Mult Scler J Exp Transl Clin· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frequency of new asymptomatic MRI lesions during attacks and follow-up of patients with NMOSD in a real-world setting.
Edgar Carnero Contentti, Pablo A Lopez, Verónica Tkachuk, Carlos Vrech, María A Zarate, Norma Deri

Mult Scler· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serological response to SARS-CoV-2 vaccines in patients with multiple sclerosis in Argentina.
Juan I Rojas, Ricardo Alonso, Mariela Cabrera, Edgar Carnero Contentti, Edgardo Cristiano, Norma Deri

Medicina (B Aires)· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Variability of the response to immunotherapy among subgroups of patients with multiple sclerosis.
Ibrahima Diouf, Charles B Malpas, Sifat Sharmin, Izanne Roos, Dana Horakova, Norma Deri

Eur J Neurol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative effectiveness in multiple sclerosis: A methodological comparison.
Izanne Roos, Ibrahima Diouf, Sifat Sharmin, Dana Horakova, Eva Kubala Havrdova, Norma Deri

Mult Scler· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disease activity after discontinuation of disease-modifying therapies in patients with multiple sclerosis in Argentina: data from the nationwide registry RelevarEM.
Zanga Gisela, Portinari Carla, Barber Josefina, Ibañez Tomas, Brolese Lucia, Deri Norma

Neurol Res· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Achieving no evidence of disease activity-3 in highly active multiple sclerosis patients treated with cladribine and monoclonal antibodies.
Ricardo Alonso, Magdalena Casas, Luciana Lazaro, Nora Fernandez Liguori, Cecilia Pita, Norma Deri

Mult Scler J Exp Transl Clin· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disability outcomes in NMOSD and MOGAD patients: data from a nationwide registry in Argentina.
Juan I Rojas, Agustín Pappolla, Liliana Patrucco, Edgardo Cristiano, Jimena Miguez, Norma Deri

Neurol Sci· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of COVID-19 after vaccination in people with multiple sclerosis in Argentina: Data from the nationwide registry RelevarEM.
Juan I Rojas, Geraldine G Luetic, Carlos Vrech, Agustín Pappolla, Liliana Patrucco, Norma Deri

Mult Scler Relat Disord· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preferences for Disease-Modifying Therapies in Argentina: Cross-Sectional Conjoint Analysis of Patients and Neurologists.
Juan I Rojas, Liliana Patrucco, Ricardo Alonso, Pablo A Lopez, Norma Deri

Value Health Reg Issues· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis